0001104659-22-119135.txt : 20221115 0001104659-22-119135.hdr.sgml : 20221115 20221115161459 ACCESSION NUMBER: 0001104659-22-119135 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221115 DATE AS OF CHANGE: 20221115 EFFECTIVENESS DATE: 20221115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hepion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-464880 FILM NUMBER: 221391328 BUSINESS ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 FORMER COMPANY: FORMER CONFORMED NAME: ContraVir Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130806 D 1 primary_doc.xml X0708 D LIVE 0001583771 Hepion Pharmaceuticals, Inc. 399 THORNALL STREET 1ST FLOOR EDISON NJ NEW JERSEY 08837 (732) 902-4000 DELAWARE None ContraVir Pharmaceuticals, Inc. Corporation true Robert Foster 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Executive Officer Director Chief Executive Officer and Director John Cavan 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Executive Officer Chief Financial Officer Todd Hobbs 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Executive Officer Chief Medical Officer Gary S. Jacobs 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director John P. Brancaccio 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director Timothy Block 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director Arnold Lippa 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director Petrus Wijngaard 399 Thornall Street First Floor Edison NJ NEW JERSEY 08837 Director Biotechnology Decline to Disclose 06b false 2022-11-04 false true true Sale and issuance of Series F preferred stock and Series G preferred stock and the underlying shares of Common Stock issuable upon the conversion thereof false 0 A.G.P./ Alliance Global Partners 8361 None None 88 POST ROAD WEST 2ND FLOOR WESTPORT CT CONNECTICUT 06880 All States false 20000000 20000000 0 false 8 1000000 true 0 0 false Hepion Pharmaceuticals, Inc. /s/ Robert Foster Robert Foster Chief Executive Officer, Director 2022-11-15